axPsA and AS adult pts exhibit different genetic risk factors & serum IL-17 levels. GUS demonstrated significant pharmacodynamic effects and clinical improvement in axPsA and non-axPsA pts. Abs 1038 #ACR22 @RheumNow https://t.co/9Rjw7usO8J
Links:
Genetic and Molecular Distinctions Between Axial Psoriatic Arthritis and Ankylo…
http://ow.ly/Tzav50Lxqhg
13-11-2022